Amy Thomas

Amy Thomas is a Senior Scientist in Analytical Development at Eli Lilly and Company, where they focus on immuno-oncological strategies to combat cancer. A graduate of the University of Illinois Chicago with a Master's in Medical Biotechnology, Amy has conducted rigorous research on targeting tumor-associated macrophages and presented findings at the AACR Annual Meeting 2023. Previously, they served as a Bioassay Scientist at Eurofins PSS Insourcing Solutions, where they optimized assays and led training initiatives. Amy’s diverse technical expertise spans immunology and molecular biology techniques, complemented by significant teaching and leadership roles. They aim to bridge academia and clinical practice to advance immuno-therapeutic approaches for improved patient outcomes.